Keating Financial Advisory Services’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785 Sell
25
-2
-7% -$84 ﹤0.01% 2241
2026
Q1
$1.49K Buy
27
+26
+2,600% +$1.24K ﹤0.01% 1955
2025
Q4
$37 Buy
+1
New +$41 ﹤0.01% 2174

Other funds holding PAHC

Keating Financial Advisory Services's PAHC Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Phibro Animal Health (PAHC) stake by 7.4% in Q2 2026, selling an estimated $84 and leaving 25 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Keating Financial Advisory Services first reported a position in PAHC in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.49K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Keating Financial Advisory Services held 25 shares of Phibro Animal Health worth $785 as of Q2 2026.
  • Keating Financial Advisory Services sold 2 Phibro Animal Health shares in Q2 2026, an estimated $84.
  • Phibro Animal Health made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2241 holding.
  • Keating Financial Advisory Services first reported a position in Phibro Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Phibro Animal Health position peaked at $1.49K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.